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Antimicrobial RNases of Human Skin
Michael Zasloff1
Included in the armamentarium of antimicrobial defenses of human skin are the 
RNases. In this issue, Abtin et al. report new details about how this antimicrobial 
system is deployed. Although present throughout the epidermis, RNases appear 
to be free to act only within the stratum corneum. Elsewhere in the epidermis 
RNases are complexed with an inhibitory protein. In the stratum corneum pro-
teases degrade the inhibitor, freeing the RNase and liberating it to function in 
antimicrobial defense.
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Human skin expresses antimicrobial 
peptides and proteins that are able to 
control the growth of microorganisms 
on its surface (Schroder and Harder, 
2006). We now know that several of 
these antimicrobial peptides, such as 
the defensins and LL-37, are expressed 
in a highly regulated fashion, produced 
both constitutively and in higher 
levels following injury, infection, or 
UV irradiation. Furthermore, we now 
appreciate that epidermal antimicrobial 
peptides, along with lipids, comprise a 
highly regulated “permeability” barrier 
that characterizes healthy human skin 
(Aberg et al., 2008). Both components 
are packaged within granules (“lamel-
lar bodies”) secreted by the kerati-
nocytes that lie beneath the stratum 
corneum. Secretion of lamellar body 
contents permits coordinated delivery 
of a “mortar” to fill the spaces between 
superficial corneocytes, thereby pro-
viding a barrier capable of both seal-
ing the surface from excessive moisture 
loss and constraining the invasion of 
microbes that colonize it. Remarkably, 
when this barrier is disrupted, a mecha-
nism is activated that restores its integ-
rity within hours. This process appears 
to involve the rapid release of “ripe” 
lamellar bodies into the stratum cor-
neum, followed by a slower activation 
of the genes that encode the compo-
nents of the lamellar bodies, including 
antimicrobial peptides and proteins. 
What actually triggers the renewal of 
the permeability barrier is uncertain. 
However, it appears that drying of the 
damaged surface is necessary, because 
covering damaged skin with a moisture-
impermeable barrier appears to impede 
recovery. It is likely that the skin senses 
a change in local osmotic pressure, but 
precisely which receptors are involved 
and how all the circuitry is connected 
have not been determined.
Substantial evidence now docu-
ments functional relevance for the 
antimicrobial peptides and proteins 
found in human skin. A mouse line in 
which the murine analog of the human 
cathelicidin LL-37 has been geneti-
cally removed is reported to be more 
susceptible to group A streptococcal 
skin infections than are wild-type mice 
(Nizet et al., 2001). The eczematous 
lesions of atopic individuals, common-
ly superinfected with Streptococcus 
aureus, are known to contain lower 
levels of several antimicrobial peptides 
(Ong et al., 2002); conversely, psoriat-
ic lesions express high levels of many 
antimicrobial peptides and proteins, 
and psoriatic skin rarely develops 
infection (Schroder and Harder, 2006). 
The protein psoriasin, abundantly 
expressed in skin, was recently shown 
to be a key antimicrobial agent in con-
trolling the growth of Escherichia coli 
on human epidermis (Glaser et al., 
2005). When human skin is treated 
with an antibody that inactivates pso-
riasin, an inoculum of E. coli, which 
would normally have been killed sec-
onds following its application to skin, 
persists in the absence of active pso-
riasin (Glaser et al., 2005). The recent 
discovery that epidermal LL-37 is 
inducible by vitamin D, along with 
the discovery that this peptide can kill 
Mycobacterium tuberculosis, indicates 
a mechanism by which phototherapy 
cures lupus vulgaris, a practice first 
established over 100 years ago by 
Finsen (Zasloff, 2006).
In this issue, Abtin et al. describe 
another, less well explored, antimicro-
bial system of human skin. Harder and 
Schröder (2002) identified RNase 7 
as an abundant antimicrobial protein 
in human epidermis while examining 
protein extracts of normal skin for anti-
microbial activity. As reported by Abtin 
et al., human keratinocytes express 
RNases 1, 4, and 5, but in far smaller 
amounts than they express RNase 7. 
Of these RNases, only RNases 5 and 7 
exhibit antimicrobial activity in vitro. 
RNases are highly basic proteins; this 
quality, in part, endows them with anti-
microbial properties (Zasloff, 2002). 
Bacteria display negatively charged 
lipids to the outside world, whether 
they be the lipopolysaccharide of 
gram-negative bacteria or the plasma 
membranes of both gram-negative and 
gram-positive bacteria. Electrostatic 
interactions bind a positively charged 
antimicrobial peptide or protein to the 
negatively charged groups on lipids; 
the peptide then incorporates itself 
within the membrane, whereupon the 
membrane’s physical and functional 
characteristics are disturbed and the 
microbe dies. In some cases, the pep-
tide or protein flips into the inner leaf-
let of the bacterial membrane, from 
which it can subsequently jump into 
the cytoplasm of the microbe, binding 
to critical cellular components and 
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disrupting function. In the case of the 
RNases, RNase 7 appears to retain its 
antimicrobial activity even when its 
catalytic activity has been inhibited, 
suggesting that it acts as a “classic” 
membrane-disruptive antimicrobial 
peptide (Huang et al., 2007). RNase 5, 
however, requires catalytic activity for 
its antimicrobial properties to be effec-
tive, suggesting that it must execute 
some of its damage within the microbe 
(Abtin et al., 2009).
At about the time of Harder and 
Schröder’s observation, Hooper and 
colleagues (2003) were examining 
genes induced within Paneth cells 
of the intestine of a germ-free mouse 
when the organ was repopulated 
with commensal microbes. An RNase 
(similar to RNase 5), “angiogenin,” 
was abundantly inducible in Paneth 
cells; this, as well as the direct dem-
onstration of its antimicrobial activ-
ity, strongly supported its role in the 
innate antimicrobial defenses of the 
intestine. Together, these studies pre-
sented a reasonably compelling case 
for RNases’ in vivo role as antimicro-
bial agents in the defense of certain 
epithelial surfaces.
These RNases are probably released 
by dying keratinocytes into the sur-
rounding intercellular space of the 
stratum corneum (Figure 1), but no 
clear process of delivery has been 
identified. It should be appreciated that 
the human gastric epithelium secretes 
histone H2A, stored within the cyto-
plasm uncomplexed with DNA, onto 
the apical surface of the epithelium. 
Apparently, a mechanism exists in the 
gastric epithelium to sequester a store 
of histone from its nuclear compart-
mentalization, localizing it for extra-
cellular secretion. Within the gastric 
lumen, pepsin cleaves H2A to yield a 
39 N-terminal fragment called bufo-
rin, which has antimicrobial activity. 
Parenthetically, this phenomenon was 
first observed in the toad Bufo bufo. 
Thus, a regulated mechanism for deliv-
ering epidermal antimicrobial RNases 
to the stratum corneum cannot be 
ruled out.
Considering the possibility of a role 
for RNase in the antimicrobial defense 
of skin, Abtin et al. apparently were 
curious about the distribution of a 
naturally occurring inhibitor of RNase 
already known to be present in human 
tissues, the protein RNase inhibitor 
(RI). The investigators demonstrated 
that although RI is abundantly pres-
ent in the lower layers of human epi-
dermis, it is not present in the stratum 
corneum. RI ordinarily wraps itself 
around its enzyme target, forming a 
complex in which both the catalytic 
and the antimicrobial properties of 
RNase 5 and RNase 7 are lost. RI is 
synthesized in the more differentiated, 
superficial layers of the epidermis, 
presumably to constrain the activity 
of the epidermal RNases in this area 
of the epidermis. As the basilar kerati-
nocytes advance to the epidermal sur-
face and are transformed to create the 
stratum corneum, proteases within this 
layer degrade RI, liberating RNases 
bound in inactive complexes. Once 
free of RI (and apparently unharmed 
by the liberating protease), RNase 5 
and RNase 7 recover their antimicro-
bial activity and defend the skin.
Abtin and colleagues’ report pro-
vokes some intriguing questions. 
Where in the microanatomy of the 
epidermis does the protease act? What 
specific protease actually degrades 
RI in its complex with RNase? Is this 
proteolytic activity regulated? When 
in the life of a dying keratinocyte is 
RNase released? When and where 
does RNase engage RI in a complex? 
Is this system inducible upon injury 
or in the setting of infection? When 
does it appear developmentally? If the 
epidermal RNase system were to fail, 
would a particular microbe occupy 
this niche?
Our epithelial surfaces are protect-
ed by antimicrobial peptides and pro-
teins, first acknowledged by Alexander 
Fleming when he discovered lysozyme 
in nasal secretions. One wonders 
when reading reports such as that of 
Abtin et al. about the benefits of wash-
ing our skin. Yes, we can wash away 
microbes. But we must remember that 
washing our skin may also deplete its 
natural armamentarium of antimicro-
bial peptides and proteins.
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Figure 1. Liberating antimicrobial rnases in the stratum corneum. RNases (such as RNase 5 and 
RNase 7) and RNase inhibitor (RI) are synthesized within the proliferating layers of the epidermis. RI 
inactivates both the antimicrobial and the catalytic activities of these RNases through complex formation 
within the deeper epidermal layers. As the keratinocytes mature and create the stratum corneum, a 
protease (not absolutely identified) degrades the RNase inhibitor, releasing the RNases, which can now 
exert their antimicrobial activity within the stratum corneum.
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Propionibacterium acnes  
and Sebaceous Lipogenesis:  
A Love–Hate Relationship?
Christos C. Zouboulis1,2
In this issue, Iinuma et al. show that Propionibacterium acnes (P. acnes)–
 conditioned medium and formalin-killed P. acnes augment intracellular 
lipid formation in hamster sebocytes by increasing the de novo synthesis of 
triacylglycerols. This commentary summarizes the current knowledge of the 
association of P. acnes with sebaceous lipogenesis, inflammation, and innate 
immunity, and points out the concurrent evidence that P. acnes–induced lipids 
may represent a recruitment of allies and/or enemies of the human skin.
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Dermatologists’ understanding of the 
association of the gram-positive, anaero-
bic Propionibacterium acnes (P. acnes, 
formerly Corynobacterium acnes) with 
acne vulgaris has changed substantially 
over the past decade (Zouboulis et al., 
2005). P. acnes has successively been 
considered (i) a bacterium responsible for 
the development of acne lesions (Brown 
and Shalita, 1998), (ii) a microbial spe-
cies with a role in aggravating acne but 
not in its initiation (Zouboulis, 2001), and 
(iii) a commensal bacterium whose pres-
ence may be skin protective and essential 
for innate immunity (Koreck et al., 2003; 
Georgel et al., 2005). Recent discoveries 
have transformed the concept of acne 
vulgaris from that of a simple temporary 
clinical problem to a model disease for 
investigating innate immunity.
The significance of the involve-
ment of P. acnes in acne pathogenesis 
remains controversial, mainly owing to 
its presence in the resident microbiota 
of healthy skin (Leyden et al. 1998). The 
recent decoding of the P. acnes genome 
revived the possibility of a pathogenic 
role (Brüggemann et al., 2004). This was 
further supported by the fact that P. acnes 
induces IL-12 and IL-8 protein production 
by primary human monocytes via a Toll-
like receptor 2 (TLR2)-regulated pathway 
and that TLR2 is expressed on the cell 
surface of macrophages surrounding 
pilosebaceous follicles of acne lesions 
(Kim et al., 2002). Moreover, functional 
TLR2 is also expressed in human kerati-
nocytes and SZ95 sebocytes (Pivarcsi et 
al., 2003; Oeff et al., 2006). TLR2 and 
TLR4 expression was increased in the 
epidermis of acne lesions, and P. acnes 
was found to induce TLR expression in 
human keratinocytes in vitro (Jugeau et 
al., 2005). On the other hand, P. acnes 
extracts have recently been implicated 
in the formation of microcomedones 
(Jarrousse et al., 2007).
P. acnes and sebaceous lipids
In this issue, Iinuma et al. (2009) show 
that P. acnes-conditioned medium and 
formalin-killed P. acnes derived from 
several P. acnes strains augment intra-
cellular formation of lipid droplets in 
hamster sebocytes by increasing the 
de novo synthesis of triacylglycerols 
in vivo and in vitro. P. acnes appears to 
participate directly in the augmentation 
of sebaceous lipo genesis through an 
increase in 15-deoxy-Δ12,14-prostaglandin 
J2 (15d-PGJ2) production, leading to 
enhanced production of diacylglycerol 
acyltransferase 1–dependent triacylgly-
c erol (Iwata et al., 2005). These results 
indicate a direct role for P. acnes in the 
enhancement of sebaceous lipogenesis 
through P. acnes-derived soluble factor(s). 
The question of whether P. acnes and/
or P. acnes-derived factors are largely 
responsible for the development of seba-
ceous lipids is considered below.
P. acnes, sebaceous lipogenesis,  
and inflammation
When applied directly to human sebo-
cyte cultures in vitro, fatty acids such 
as arachidonic acid (AA), a long-chain, 
proinflammatory ω-6 fatty acid and pre-
cursor of leukotriene B4 (LTB4; Alestas et 
al., 2006), and linoleic acid, an essential 
dietary fatty acid (Wróbel et al., 2003), 
stimulate IL-6 and IL-8 synthesis and 
enhance the synthesis of sebaceous lip-
ids. 5-Lipoxygenase (5-LOX) metabolizes 
AA to LTB4, which induces recruitment 
and activation of neutrophils, monocytes, 
and eosinophils. It also stimulates the 
production of several proinflammatory 
